Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey.

Parigi, Tommaso Lorenzo; Vieujean, Sophie; Paridaens, Kristine; Dalgaard, Kira; Peyrin-Biroulet, Laurent; Danese, Silvio

Parigi, Tommaso Lorenzo; Vieujean, Sophie; Paridaens, Kristine; Dalgaard, Kira; Peyrin-Biroulet, Laurent; Danese, Silvio.

Afiliação

Parigi TL; Department of Gastroenterology and Digestive Endoscopy, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Vieujean S; Division of Immunology, Transplantation and Infectious Disease, Università Vita Salute San Raffele, 20132 Milan, Italy.
Paridaens K; Hepato-Gastroenterology and Digestive Oncology, University Hospital CHU of Liège, 4000 Liège, Belgium.
Dalgaard K; Ferring International Center S.A., CH-1162 Saint-Prex, Switzerland.
Peyrin-Biroulet L; Ferring Pharmaceuticals A/S, 2770 Kastrup, Denmark.
Danese S; Department of Gastroenterology, Nancy University Hospital, F-54500 VandÅuvre-lès-Nancy, France.

Microorganisms ; 11(11)2023 Nov 19.

Article em En | MEDLINE | ID: mdl-38004817

Palavras-chave

Crohn's disease; antibiotics; fecal microbial transplant; inflammatory bowel disease; irritable bowel syndrome; microbiota; pouchitis; probiotics; ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Microorganisms Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google